Showing results (81-90 of 92) with videos related to
Sort By:
Pageof 10
Journal of Virology|March 28, 2008
Proteomics analysis unravels the functional repertoire of coronavirus nonstructural protein 3Benjamin W Neuman, Jeremiah S Joseph, Kumar S Saikatendu, et al.ACS Medicinal Chemistry Letters|June 19, 2024
SARS-CoV-2 Main Protease Inhibitors That Leverage Unique Interactions with the Solvent Exposed S3 Site of the EnzymeLauren R Blankenship, Kai S Yang, Veerabhadra R Vulupala, et al.Journal of Medicinal Chemistry|April 12, 2024
Discovery of First-in-Class PROTAC Degraders of SARS-CoV-2 Main ProteaseYugendar R Alugubelli, Jing Xiao, Kaustav Khatua, et al.Journal of Structural Biology|December 7, 2010
A structural analysis of M protein in coronavirus assembly and morphologyBenjamin W Neuman, Gabriella Kiss, Andreas H Kunding, et al.Science Advances|April 8, 2026
From vibrations to function: Spectroscopic detection and quantification of π-π stacking in drug-responsive protein complexesNarangerel Altangerel, Esther J Ocola, Benjamin W Neuman, et al.ACS Central Science|March 1, 2022
Evaluation of SARS-CoV-2 Main Protease Inhibitors Using a Novel Cell-Based AssayWenyue Cao, Chia-Chuan Dean Cho, Zhi Zachary Geng, et al.Journal of the American Chemical Society|April 14, 2026
Nicotine-Inspired, De Novo-Designed SARS-CoV-2 Main Protease Inhibitors Reveal Unique Chemistry for Covalently Conjugating Both Cysteine and Histidine Residues in the Catalytic DyadSandeep Atla, Veerabhadra Vulupala, Yugendar R Alugubelli, et al.Nature Communications|February 14, 2026
From nicotine to SARS-CoV-2 antivirals with potent in vivo efficacy and a broad anti-coronavirus spectrumKaustav Khatua, Sandeep Atla, Demonta Coleman, et al.Biorxiv : the Preprint Server for Biology|April 24, 2023
An Azapeptide Platform in Conjunction with Covalent Warheads to Uncover High-Potency Inhibitors for SARS-CoV-2 Main ProteaseKaustav Khatua, Yugendar R Alugubelli, Kai S Yang, et al.Antiviral Research|March 30, 2024
Azapeptides with unique covalent warheads as SARS-CoV-2 main protease inhibitorsKaustav Khatua, Yugendar R Alugubelli, Kai S Yang, et al.Pageof 10